ANMA Home

Code of Ethics

Top Stories
  Naturopathic Legislative Alert!    NEW!
  Florida Sunrise Report
  
CA Legislation 
   Arizona's Opinion
   Nat. Scandal in AZ
   Nat. School Under Fire
   CNME, "otherwise not
   approved accred. agency"
   History & Demise of CNME
   AANP vs. Hayhurst & ANMA
         AANP Loses Again

27th Annual Convention (7/25/08)        Convention Lecture
    & Workshop Schedule

   Convention Registration Form

Legislation
   Alaska
   Naturopathic State Laws
   Response to the "OAND"
   Washington Legislation

Journal of the American Naturopathic Medical Association (JANMA)
   Vol. 12 No. 2   07/08    NEW  !
   Vol. 11 No. 3   10/07
   Vol. 11 No. 2   06/07
   Vol. 11 No. 1   02/07
   Vol. 10 No. 4   11/06
   Vol. 10 No. 3   07/06
   Vol. 10 No. 2   04/06
   Vol. 10 No. 1   01/06
   Vol. 9 No. 3     10/05
   Vol. 9 No. 2     07/05
   Vol. 9 No. 1     04/05
   Vol. 8 No. 4     12/04
   Vol. 8 No. 2     07/04
   Vol. 8 No. 1     03/04
   Vol. 7 No. 4     12/03
   Vol. 7 No. 3     09/03
   Vol. 7 No. 2     06/03
   Vol. 7 No. 1     04/03
   Vol. 6 No. 4
   Vol. 6 No. 3
   Vol. 6 No. 2
   Vol. 6 No. 1
   Vol. 5 No. 4
   Vol. 5 No. 3
   Vol. 5 No. 2
   Vol. 5 No. 1
   Vol. 4 No. 4
   Vol. 4 No. 3
   Vol. 4 No. 2
   Vol. 4 No. 1

Facts
   History & Demise of CNME
   CNME Bites The Dust!
   Caution Nat. Med. Edu.
   Naturopaths In Denial
   Fraud?
   NH Gov. Cavalier Response
   Ltr. to AANP From NH Leg.
   NCNM Student Remarks
:
       Merry Bern Letter
      
Stephen Sporn
   NCNM Student Report
   Media
   Canada
   Response to the "OAND"
   Naturopathic Lawsuits

      
Lawsuit #1
      
Lawsuit #2
   Licensing Vs. Certification 

ANMA Memorabilia

Application

American Naturopathic
Certification Board

Naturopathic Links

E-mail

 

ANMA ONLINE REFERENCES
Volume 4 Number 1

 

 

NUTRITIONAL INTERVENTIONS FOR THE THYROID

By: Robert J. Thiel, Ph.D., Naturopath

 

REFERENCES

[1] Sawin CT. Subclinical hypothyroidism in older persons. Clin Ger Med 1995;11(2):231-238

[2] Many thyroid conditions are underdiagnosed. Med Tribune, Jan 25, 1996;2

[3] Ingram C. Who Needs Headaches? Literary Visions, Hiawatha (IA), 1991

[4] Woeber KA. Subclinical hypothyroid dysfunction. Arch Int Med 1997;157:1065-1068

[5] Bakke J. Rethinking thyroid guidelines. Cortlandt Forum 1991; 46-20:79

[6] Many thyroid conditions are underdiagnosed. Med Trib, Jan 25,1996;2

[7] Luboshitzky R, et al. Prevalence of cognitive dysfunction and hypothyroidism in an elderly community population. Isr J Med Sci,1996;32(1):60-65

[8] Wiersinga WM. Subclinical hypothyroidism and hyperthyroidism: prevalence in clinical practice. Neth J Med,1995;46:197-204

[9] Mulder JE. Thyroid disease in women. Med Clin North Am,1998;82(1):103-125

[10] Colzani R, Fang SL, Alex S, Braverman LE. The effect of nicotine on thyroid function in rats. Metabolism,1998;47(2):154-157

[11] Franklyn J. Subclinical hypothyroidism: To treat or not to treat, that is the question. Clin Endocrinol,1995;43:443-444

[12] Haggerty JJ, et al. Subclinical hypothyroidism: A modifiable risk factor for depression? Am J Psychiatry,1993;150(3):508-510

[13] Hickie I, et al. Clinical and subclinical hypothyroidism in patients with chronic and treatment-resistant depression. Aust NZ J Psychiatry,1996;30(2):246-252

[14] Pies RW. The diagnosis and treatment of subclinical hypothyroid states in depressed patients. Gen Hosp Psychiatry,1997;19(5):344-354

[15] Ricart-Engel W, et al. The relation between thyroid function and nutritional status in HIV-infected patients. Clin Endocrinol, 1996;44(1):53-58

[16] Hetzel BS, Clugston GA. Iodine. In Modern Nutrition in Health and Disease, 9th ed. Williams & Wilkins, Balt., 1999:253-264

[17] Duncan AM, et al. Modest hormonal effects of soy isoflavones in postmenopausal women. J Clin Endocrinol Metab, 1999;84(10):3479-3484

[18] DeCava JA. Underactive and overactive thyroid. Nutr News & Views, 1999;3(4):108

[19] Robinson J, Rall JE, Gordon P. The Thyroid and Iodine Metabolism. In: DuncanĘs Diseases of Metabolism, 7th ed. WB Saunders, Phil.:1009-1104, 1974

[20] Guyton AC, Hall JE. Textbook of Medical Physiology, 9th ed. W.B. Saunders, Phil., 1996

[21] The Merck Manual of Diagnosis and Therapy, 14th ed. Merck & Co: Rahway (NJ), 1982

[22] Mishkin, B. Standards of Care for Headache Diagnosis and Treatment. National Headache Foundation: Chicago, 1996

[23] Wright JS. A Guide to Organic Drugs of the United States Pharmacopoeia 1916. Eli Lilly, Indianapolis, 1917

[24] Ensminger AH, Ensminger ME, Konlande JE, Robson JRK. Food & Nutrition Encyclopedia, 2nd ed. CRC Press, New York, 1993

[25] Thiel R. Serious Nutrition for Health Care Professionals. California Health Group: Arroyo Grande (CA),1994

[26] Murray RK, et al. HarperĘs Biochemistry. Appleton and Lange, Stamford (CT),1996

[27] Nunez S, Leclere J. Diagnosis of hypothyroidism in the adult. Rev Prat, 1998;48(18):1993-1998

[28] Zulewski H, et al. Estimation of tissue hypothyroidism by a new clinical score: evaluation of patients with various grades of hypothyroidism and controls. J Clin Endocrinol Metab,1997;82(3):771-776

[29] Lerch M, Meier C, Staub JJ. Is there a need for treatment in subclinical hypo- and hyperthyroidism. Ther Umch, 1999;56(7):369-373

[30] Adlin V. Subclinical hypothyroidism: deciding when to treat. Am Fam

Physician,1998;57(4):776-780

[31] PhysicianĘs Desk Reference, 54th ed. Medical Economics, Montvale (NJ), 2000

[32] Thiel R. Natural interventions for migraine headache sufferers. ANMA Monitor,1998;2(3):5-9

[33] Thiel R. Natural interventions for ADD and ADHD. ANMA Monitor,1997;1(3):5-8

[34] Thiel R. Chronic fatigue assessment and intervention: The result of 101 cases. ANMA & AANC J,1996;1(3)17-19

[35] Wartofsky L. Use of sensitive TSH assay to determine optimal thyroid hormone therapy to avoid osteoporosis. Annu Rev Med,1991;42:341-345

[36] Foldes J, et al. Bone mineral density in patients with endogenous subclinical hyperthyroidism: is this thyroid status a risk factor for osteoporosis. Clin Endocrinol,1993;39(5):521-527

[37] Langdahl BL. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy? J Bone Min Res,1997;12(1):78-88

[38] Fowler PB, McIvor J, Sykes L, Macrae KD. The effect of long-term thyroxine on bone mineral density and serum cholesterol. J R Coll Physicians Lond,1996;30(6):527-532

[39] Erlacher L, et al. Salmon calcitonin and calcium in the treatment of male osteoporosis: the effect on bone mineral density. Wein Klin Wochenschr,1997;109(8):270-274

[40] Dellovade TL, Zhu YS, Krey L, Pfaff DW. Thyroid hormone and estrogen interact to regulate behavior. Proc Natl Acad Sci, 1996;93:12581-12586

[41] Perez-Jaraiz MD. Prophylaxis of osteoporosis with calcium, estrogens and/or eel calcitonin. Maturitas,1996;23(6):327-332

[42] Wagner W and Nootbaar-Wagner U. Prophylactic treatment of migraine with gamma-linolenic and alpha-linolenic acids. Cephalgia 1997;17(2):127-130

[43] Elsas LJ, Acosta PB. Nutritional support of inherited metabolic disease. In Modern Nutrition in Health and Disease, 9th ed. Williams & Wilkins, Balt., 1999: 1003-1056

[44] Scalzo R. Naturopathic Handbook of Herbal Formulas. Kivaki Press, Durango (CO), 1994

[45] Tenney L. Herb Handbook. Woodland Books, Provo, 1987

[46] PDR for Herbal Medicines. Medical Economics, Montvale (NJ), 1998

[47] McGuffin, et al. American Herbal Products AssociationĘs Botanical Safety Handbook, CRC Press, New York, 1997

[48] Key, et al. Raised thyroid stimulating hormone associated with kelp intakes in British vegan men. J Human Nutr, 1992;5:323-326

[49] Null G. The Complete Encyclopedia of Natural Health. Kensington Books, New York, 1998

[50] McAnalley B. A solid scientific foundation. Breakthrough, 1997;2(1):5-7

[51] Burk RF, Levander OA. Selenium. In Modern Nutrition in Health and Disease, 9th ed. Williams & Wilkins, Balt.,1999:265-276

[52] King JC, Keen CL. Zinc. In Modern Nutrition in Health and Disease, 9th ed. Williams & Wilkins, Balt.,1999:223-239

[53] DeCava JA. Glandular supplements. Nutr News & Views 1997; 1(3):1-10

[54] Burns D. Growing scientific evidence support glandular therapy. Digest Chiropractic Econ, Nov/Dec 1987:74-79

[55] Schwartz EF. Glandular therapy. Am Chiropractor, Jan/Feb 1983:14-18

[56] Harrower H. Practical Organotherapy, 3rd ed. W.B. Conkey, Hammond (IN), 1921

[57] Gardner M. Intestinal absorption of intact peptides and protein from the diet - a neglected field? Biologic Rev,1984;59:289-331

[58] Popov IM, et al. Cell therapy. J Intl Acad Prev Med,1977;3:74-82

[59] Lathan R. Chronic fatigue? Consider hypothyroidism. Physician & Sports Med,1991;19(10):67-70

[60] Duarte A. Health Alternatives. Mega Systems, Morton Grove (IL), 1995

[61] Spiller GA. Metabolism and physiological effects of methylxanthines. In: Caffeine. CRC Press: New York: 225-231, 1997

[62] Smith BD and Tola K. Caffeine: effects on psychological functioning and performance In: Caffeine. CRC Press: New York: 251-299, 1997

[63] Iancu I and Dolberg OT. Is caffeine involved in the pathogenesis of combat-stress reaction? Military Med, 1996;161(4):230-232

[64] Lundsberg LS. Caffeine consumption. In: Caffeine. CRC Press: New York: 199-224, 1997

[65] Roberts, HR, et al. Caffeine consumption. Food & Chem Toxicology, 1996;34(1):119-129

[66] Shi X and Dalal NS. Antioxidant behavior of caffeine: Efficient scavenging of hydroxyl radicals. Food & Chem Toxicology 1991;29(1):1-6

[67] Caffeine-withdrawal headache in post-operative patients. Fam Prac Recertification, 1992;14(8):47

[68] James JE. Caffeine, health and commercial interests: Responding to Golding. Addiction 1995;90:985-990

 

OXIDATIVE MEDICINE

By: Robert L. White, N.D., Ph.D., P.A.-C.

REFERENCES

 

1. Harmon, Denham, "Aging; A Theory Based on Free Radical and Radiation Chemistry," UCRS-3078, Unclassified Health and Biology, Contract No. W-7405-eng-48.

2. Harmon, Denham, "Prolongation of the Normal Life Span by Radiation Protection Chemicals." Clin Res Proc 5:46, 1957.

3. Del Maestro RF, Thaw HH, Bjork J, et al: Free Radicals as Mediators of Tissue Injury. Acta PhysiolScand 1980; 492 (suppl)43-57.

4. Rowley DA and Halliwell B: Formation of Hydroxyl Radicals from Hydrogen Peroxide and Iron Salts by Superoxide and Ascorbate Dependent Mechanisms: Relevance to the Pathology of Rheumatoid Disease. Clin Sci 1983; 64: 649-653.

5. Didenko VV: Possible Role of Lipid Peroxidation in the Pathogenesis of Arrhythmias in Myocardial Infarction. Biull Eksp Biol Med 1985; 99(6): 647-649.

6. Minotti G and Aust SD: The Requirement of Iron (III) in the Initiation of Lipid Peroxidation by Iron (II) and Hydrogen Peroxide. J Biol Chem 1987: 262 (3): 1098-1104

7. Morehouse LA, Tien M, Bucher JR, et al: Effect of Hydrogen Peroxide on the Initiation of Microsomal Lipid Peroxidation. Biochem Pharm 1983; 32: 123-127

8. Tappel, AL: Lipid Peroxidation Damage to Cell Component. Fed Proc 1973; 32: 1870

9. Oliver TH, Cantab BC and Murphy DV: Influenzal Intravenous Injection of Hydrogen Peroxide. Lancet 1920; 1: 432-433

10. Ramasarma T: Generation of H2O2 in Biomembranes. Biochemica et Biophysica ACTA 1982; 694: 69 - 93

11. Root RK, Metcalf JA, Oshino N, et al: H2O2 Release from Human Granulocytes during Phagocytosis. J Clin Invest 1975; 55: 945 - 955

12. Root RK and Metcalf JA: H2O2 Release from Human Granulocytes during Phagocytosis. J Clin Invest 1977; 60: 1266 - 1279.

13. Munakata T, Semba U, Shibuya, et al: Induction of Interferon - Gamma Production by Human Natural Killer Cells Stimulated by Hydrogen Peroxide. J Immunol 1985; 134(4): 2449 - 2455.

14. Howard DH: Studies on the Catalase of Histoplasma Capsulatum. Infect Immun 1983; 39(3): 1161 - 1166.

15. Harrison JF, and Schultz J: Studies on the Chlorinating Activity of Myeloperoxidase. J Biol Chem 1976: 251: 1371 - 1374.

16. Zgiicyznski JM, Selvaraj RJ, Paul BB, et al: Chlorination by the Myeloperoxidase - H2O2 - Cl Antimicrobial System at Acid and Neutral pH. Proc Soc Exp Biol Med 1977; 154: 418 - 422.

17. Thomas EL: Myeloperoxidase, Hydrogen Peroxide, Chloride Antimicrobial System; Nitrogen-Chlorine Derivatives of Bacteria (Components in Bacteria) Action against Eschericia Coli. Infec Immun 1979; 23: 522 - 531.

18. Tenovuo J, Makinen & Sievers G: Antibacterial Effect of Lactoperoxidase and Myeloperoxidase against Bacillus Aureus. Antimicrob Agents Chemother 1985; 27(1): 96 - 101.

19. Hess ML, Manson NH, Lower RR: Leukocyte generated Hydrogen Peroxide Depression of Cardiac Sarcoplasmic Reticulum Calcium Transport. Transplantation 1983; 36 (1): 117 - 119.

20. Urschel HC, Finney JW, Morale AR, et al: Cardiac Resuscitation with Hydrogen Peroxide. Circ 1965; 31(suppl 11): 11 - 21.

21.Finney JW, Urschel HC, Balla GA, et al: Protection of the Ischemic Heart with DMSO alone or DMSO with Hydrogen Peroxide. Ann NY Acad Sci 1967; 151: 231 - 241

22. Balla GA, Finney JW, Aronof BL, et al: Use of Intravenous Hydrogen Peroxide to Promote Wound Healing. Am J Surg 1964: 108: 621 - 629.

23. Fuson RI, Kylstra JA, Hochstein P, et al: Intravenous Hydrogen Peroxide Infusion as a Means of ExtraPulmonary Oxygenation. Clin Res 1967; 15: 74

24. Jay BE, Finney JW, Balla GA, et al: The Supersaturation of Biologic Fluids with Oxygen by the Decomposition of Hydrogen Peroxide. Texas Repts Biol and Med 1964; 22: 106 - 109.

25. Finney JW, Balla GA, Race GJ, et al: Peripheral Blood Changes in Humans and Experimental Animals Following the Infusion of Hydrogen Peroxide into the Carotid Artery. Angioolgy 1965; 16: 62 - 66.

26. Finney JW, Jay BE, Race GJ, et al: Removal of Cholesterol and Other Lipids from Experimental Animal and Human Atheromatous Arteries by Dilute Hydrogen Peroxide. Angiology 1966; 17: 223 - 228.

27. Farr Ch: Physiological and Biochemical Responses to Intravenous Hydrogen Peroxide in Man. J. ACAM 1988; 1: 113 - 129.

28. Farr, CH: Possible Therapeutic Value of Intravenous Hydrogen Peroxide. Plzen.lek Sborn., Suppl. 56 1988: 171 - 173.

29. Farr CH: The Therapeutic Use of Intravenous Hydrogen Peroxide (Monograph). Genesis Medical Center, Oklahoma City, Ok.: Jan 1987.

30. Proceedings of International Conferences on Bio-Oxidative Medicine (1989, 1990, 1991). Available from the IBOM Foundation, P.O. Box 13205, Oklahoma City, Ok., 73113-1205